Skip to content

Insider · CIK 0001722649

Stefan Galluppi

officer

Files at LFMD (LifeMD, Inc.). First filing Jun 17, 2025, latest Jun 17, 2025.

In brief

Stefan Galluppi files SEC Form 4 as officer at LFMD (LifeMD, Inc.). Since Jun 17, 2025, Stefan Galluppi has reported 0 open-market buys worth $0 and 1 open-market sell worth $1.1M, the latest filed on Jun 17, 2025.

A track record needs three past buys with six months of prices behind them; Stefan Galluppi has 0, so none is measured yet.

The newest scored trade: sold $1.1M of LFMD on Jun 13, 2025, filed Jun 17, 2025, scored 55 (moderate), under a 10b5-1 plan.

Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 1
$0 bought, $1.1M sold

Where the trades landed

Last year at the company this insider has traded most, with each buy and sell on the bar it happened.

LFMD: LifeMD, Inc.

LFMDOct 9, 2026 · close 2.63

Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™

Signals

This insider’s open-market buys and sells, scored.

ScoreCompanyValueHoldingsPrice contextFiled
55Moderate
LFMDsell 410b5-1
LifeMD, Inc.
$1.1M
85,000 shares
-51%+205% from low-3% from high

Planned sales

Form 144 notices this insider filed before selling restricted or control stock, newest first.

FiledCompanySharesValueSale datePast 3 months
Jun 13, 2025 LFMD
LifeMD, Inc.
85,000
0.19% of outstanding
$1.1MJun 13, 2025none

Transactions

Every row this insider has filed, 5 in all, newest first.

DateCompanyTransactionSharesPriceValueHoldings afterFiled
Aug 22, 2025LFMD
LifeMD, Inc.
AGrant or award
Common Stock
+30,000$0.00$0110,449Aug 26, 2025
Jun 13, 2025LFMD
LifeMD, Inc.
SOpen-market sale
Common Stock10b5-1
-85,000$12.38$1.1M80,449Jun 17, 2025
Mar 31, 2025LFMD
LifeMD, Inc.
AGrant or award
Common Stock
+30,000$0.00$0165,449Apr 2, 2025
Mar 7, 2025LFMD
LifeMD, Inc.
AGrant or award
Common Stock
+30,000$0.00$0135,449Mar 11, 2025
Mar 6, 2025LFMD
LifeMD, Inc.
AGrant or award
Common Shares
+60,000$0.00$0105,449Mar 10, 2025

Questions about Stefan Galluppi

Answered from the filings on this page, as of the latest one.

Is Stefan Galluppi buying or selling?

Not in the last 12 months. Stefan Galluppi's latest open-market trade on SEC Form 4 was sold $1.1M of LFMD on Jun 13, 2025.

How did Stefan Galluppi's past buys perform?

Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Stefan Galluppi has 0.

Where does Stefan Galluppi file Form 4?

Stefan Galluppi has filed Form 4 at LFMD (LifeMD, Inc.) as Chief Innovation Officer. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

Stefan Galluppi: insider trades and track record | InsiderTell